← Mechanisms of action
P2RY12
SINGLE PROTEINHomo sapiens
Preferred name: Purinergic receptor P2Y12 ChEMBL ↗
Linked proteins
Drugs acting on this target (15)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| act-281959 | Antagonist | experimental | Small molecule | P2RY12 antagonist |
| cangrelor (kengreal) | Antagonist | approved | Small molecule | P2RY12 antagonist |
| clopidogrel (plavix) | Antagonist | approved | Small molecule | P2RY12 antagonist |
| elinogrel | Antagonist | experimental | Small molecule | P2RY12 antagonist |
| prasugrel (effient) | Antagonist | approved | Small molecule | P2RY12 antagonist |
| regrelor disodium | Antagonist | experimental | Small molecule | P2RY12 antagonist |
| selatogrel | Antagonist | experimental | Small molecule | Purinergic receptor P2Y12 antagonist |
| ticagrelor (brilinta) | Antagonist | approved | Small molecule | P2RY12 antagonist |
| ticlopidine (ticlid) | Antagonist | approved | Small molecule | P2RY12 antagonist |
| thienoyridine | Immunity, active | experimental | Small molecule | P2RY12 immunity, active |
| cangrelor (kengreal) | Inhibitor | approved | Small molecule | Purinergic receptor P2Y12 inhibitor |
| p2611222 | Inhibitor | experimental | Small molecule | P2RY12 inhibitor |
| selatogrel | Inhibitor | experimental | Small molecule | P2RY12 inhibitor |
| tipidogrel | Inhibitor | experimental | Small molecule | P2RY12 inhibitor |
| vicagrel | Inhibitor | experimental | Small molecule | P2RY12 inhibitor |